The iddm4 locus segregates with diabetes susceptibility in congenic WF.iddm4 rats
| dc.contributor.author | Mordes, John P. | |
| dc.contributor.author | Leif, Jean H. | |
| dc.contributor.author | Novak, Stephen | |
| dc.contributor.author | DeScipio, Cheryl | |
| dc.contributor.author | Greiner, Dale L. | |
| dc.contributor.author | Blankenhorn, Elizabeth P. | |
| dc.date | 2022-08-11T08:10:01.000 | |
| dc.date.accessioned | 2022-08-23T16:52:18Z | |
| dc.date.available | 2022-08-23T16:52:18Z | |
| dc.date.issued | 2002-10-29 | |
| dc.date.submitted | 2008-07-09 | |
| dc.identifier.citation | <p>Diabetes. 2002 Nov;51(11):3254-62.</p> | |
| dc.identifier.issn | 0012-1797 (Print) | |
| dc.identifier.pmid | 12401717 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/42027 | |
| dc.description.abstract | Viral antibody-free BBDR and WF rats never develop spontaneous diabetes. BBDR rats, however, develop autoimmune diabetes after perturbation of the immune system, e.g., by viral infection. We previously identified a disease-susceptibility locus in the BBDR rat, iddm4, which is associated with the development of autoimmune diabetes after treatment with polyinosinic:polycytidylic acid and an antibody that depletes ART2(+) regulatory cells. We have now developed lines of congenic WF.iddm4 rats and report that in an intercross of N5 generation WF.iddm4 rats, approximately 70% of animals either homozygous or heterozygous for the BBDR origin allele of iddm4 became hyperglycemic after treatment to induce diabetes. Fewer than 20% of rats expressing the WF origin allele of iddm4 became diabetic. Testing the progeny of various recombinant N5 WF.iddm4 congenic rats for susceptibility to diabetes suggests that iddm4 is centered on a small segment of chromosome 4 bounded by the proximal marker D4Rat135 and the distal marker D4Got51, an interval of | |
| dc.language.iso | en_US | |
| dc.relation | <p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=12401717&dopt=Abstract">Link to Article in PubMed</a></p> | |
| dc.relation.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034451/ | |
| dc.subject | Adoptive Transfer | |
| dc.subject | Alleles | |
| dc.subject | Animals | |
| dc.subject | *Chromosome Mapping | |
| dc.subject | Diabetes Mellitus, Type 1 | |
| dc.subject | Disease Models, Animal | |
| dc.subject | Genetic Markers | |
| dc.subject | Genetic Predisposition to Disease | |
| dc.subject | Homozygote | |
| dc.subject | Islets of Langerhans | |
| dc.subject | Pancreatic Diseases | |
| dc.subject | Rats | |
| dc.subject | Rats, Mutant Strains | |
| dc.subject | Life Sciences | |
| dc.subject | Medicine and Health Sciences | |
| dc.title | The iddm4 locus segregates with diabetes susceptibility in congenic WF.iddm4 rats | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Diabetes | |
| dc.source.volume | 51 | |
| dc.source.issue | 11 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/oapubs/483 | |
| dc.identifier.contextkey | 544965 | |
| html.description.abstract | <p>Viral antibody-free BBDR and WF rats never develop spontaneous diabetes. BBDR rats, however, develop autoimmune diabetes after perturbation of the immune system, e.g., by viral infection. We previously identified a disease-susceptibility locus in the BBDR rat, iddm4, which is associated with the development of autoimmune diabetes after treatment with polyinosinic:polycytidylic acid and an antibody that depletes ART2(+) regulatory cells. We have now developed lines of congenic WF.iddm4 rats and report that in an intercross of N5 generation WF.iddm4 rats, approximately 70% of animals either homozygous or heterozygous for the BBDR origin allele of iddm4 became hyperglycemic after treatment to induce diabetes. Fewer than 20% of rats expressing the WF origin allele of iddm4 became diabetic. Testing the progeny of various recombinant N5 WF.iddm4 congenic rats for susceptibility to diabetes suggests that iddm4 is centered on a small segment of chromosome 4 bounded by the proximal marker D4Rat135 and the distal marker D4Got51, an interval of</p> | |
| dc.identifier.submissionpath | oapubs/483 | |
| dc.contributor.department | Department of Pathology | |
| dc.contributor.department | Department of Medicine, Diabetes Division | |
| dc.source.pages | 3254-62 |